Rechallenge with Multi-Targeted Tyrosine Kinase Inhibitors in Patients with Advanced Soft Tissue Sarcoma: A Single-Center Experience

PURPOSE: Chemotherapy and multi-targeted tyrosine kinase inhibitors (TKI) are important treatments for advanced soft tissue sarcomas, but the following treatment remains unclear after the failure of these drugs. This retrospective study investigated the efficacy and safety of multi-targeted TKI rech...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Deng, Yao-Tiao, Wu, Xin, Jiang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987272/
https://www.ncbi.nlm.nih.gov/pubmed/33776477
http://dx.doi.org/10.2147/CMAR.S300430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987272/
https://www.ncbi.nlm.nih.gov/pubmed/33776477
http://dx.doi.org/10.2147/CMAR.S300430

Ejemplares similares